LAVI.AT
Price:
$0.846
Market Cap:
$143.01M
Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, general medicine, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products. The company was founded in 1911 and is based in Paiania, Greece.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1995-11-08
Stock Exchange
ATH
Ticker
LAVI.AT
According to Lavipharm S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 165.25M. This represents a change of 4.41% compared to the average of 158.26M of the last 4 quarters.
The mean historical Enterprise Value of Lavipharm S.A. over the last ten years is 70.74M. The current 165.25M Enterprise Value has changed 23.26% with respect to the historical average. Over the past ten years (40 quarters), LAVI.AT's Enterprise Value was at its highest in in the June 2024 quarter at 161.80M. The Enterprise Value was at its lowest in in the June 2022 quarter at 40.35M.
Average
70.74M
Median
45.49M
Minimum
27.09M
Maximum
157.56M
Discovering the peaks and valleys of Lavipharm S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 481.60%
Maximum Annual Enterprise Value = 157.56M
Minimum Annual Increase = -46.83%
Minimum Annual Enterprise Value = 27.09M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 156.32M | -0.79% |
| 2023 | 157.56M | 481.60% |
| 2022 | 27.09M | -40.55% |
| 2021 | 45.57M | 0.16% |
| 2020 | 45.49M | 6.48% |
| 2019 | 42.73M | 3.99% |
| 2018 | 41.09M | -2.01% |
| 2017 | 41.93M | -46.83% |
The current Enterprise Value of Lavipharm S.A. (LAVI.AT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
113.66M
5-year avg
86.41M
10-year avg
70.74M
Lavipharm S.A.’s Enterprise Value is
| Company | Enterprise Value | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lavipharm S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lavipharm S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lavipharm S.A.'s Enterprise Value?
What is the highest Enterprise Value for Lavipharm S.A. (LAVI.AT)?
What is the 3-year average Enterprise Value for Lavipharm S.A. (LAVI.AT)?
What is the 5-year average Enterprise Value for Lavipharm S.A. (LAVI.AT)?
How does the current Enterprise Value for Lavipharm S.A. (LAVI.AT) compare to its historical average?